Cargando…

The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study

BACKGROUND: Comorbidity has a well documented detrimental effect on cancer survival. However it is difficult to disentangle the direct effects of comorbidity on survival from indirect effects via the influence of comorbidity on treatment choice. This study aimed to assess the impact of comorbidity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarfati, Diana, Hill, Sarah, Blakely, Tony, Robson, Bridget, Purdie, Gordon, Dennett, Elizabeth, Cormack, Donna, Dew, Kevin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678274/ https://www.ncbi.nlm.nih.gov/pubmed/19379520 http://dx.doi.org/10.1186/1471-2407-9-116

Ejemplares similares

Cancer care coordinators in stage III colon cancer: a cost-utility analysis
por: Blakely, Tony, et al.
Publicado: (2015)

Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study
por: Brewer, Naomi, et al.
Publicado: (2011)

Ethnic and socioeconomic trends in breast cancer incidence in New Zealand
por: Cunningham, Ruth, et al.
Publicado: (2010)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

The impact of patient comorbidity on cancer stage at diagnosis
por: Gurney, Jason, et al.
Publicado: (2015)

Regional variation in post‐operative mortality in New Zealand
por: Gurney, Jason K., et al.
Publicado: (2022)

Age standardisation – an indigenous standard?
por: Robson, Bridget, et al.
Publicado: (2007)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis
por: Boakye, Daniel, et al.
Publicado: (2021)

Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
por: Liu, Lin-Lin, et al.
Publicado: (2022)

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
por: Breadner, Daniel, et al.
Publicado: (2022)

The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
por: Collienne, Maike, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes
por: Sarfati, Diana, et al.
Publicado: (2014)

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
por: Morris, M, et al.
Publicado: (2007)

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans
por: Aspinall, Sherrie L, et al.
Publicado: (2015)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
por: Jeon, Hyeong-Joon, et al.
Publicado: (2011)

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
por: Joshi, Rohit
Publicado: (2013)

Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
por: Oki, Eiji, et al.
Publicado: (2021)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
por: Gao, Peng, et al.
Publicado: (2018)

Changes in Body Composition during Adjuvant FOLFOX Chemotherapy and Overall Survival in Non-Metastatic Colon Cancer
por: Chung, Eric, et al.
Publicado: (2019)

Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020)

Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021)

The association between the lymph node ratio, surgical margin, and survival in patients with colon cancer receiving adjuvant chemotherapy
por: Fidan, Evren, et al.
Publicado: (2022)

Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up
por: Teng, Andrea M., et al.
Publicado: (2016)

Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
por: Luo, Yong, et al.
Publicado: (2020)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
por: Yang, Yan, et al.
Publicado: (2018)

Correction: Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020)

The Prognostic Value of Adjuvant Chemotherapy in Colon Cancer With Solitary Tumor Deposit
por: Lin, Qiangkang, et al.
Publicado: (2022)

Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review
por: Pilleron, Sophie, et al.
Publicado: (2021)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma
por: Jung, Seung Pil, et al.
Publicado: (2012)

Adjuvant chemotherapy in carcinoma colon: Is there a rationale to change practice for Asian patients?
por: Rangarajan, Bharath, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hk7fm0fq05b2uleq7h5o8ih3su